Recently, Fu Huidong, Chairman of the Hebei Provincial Federation of Returned Overseas Chinese, Wang Jingchao, Secretary of the Cangzhou Federation of Returned Overseas Chinese, and Cheng Xiuzhen, Member of the Party Working Committee of Cangzhou Bohai New Area, Standing Committee Member of Huanghua Municipal Committee, and Minister of the United Front Work Department, along with other departmental leaders, visited Laviana Pharma (Cangzhou) Co., Ltd. for research. They focused on examining the company's innovative achievements in pharmaceutical R&D, intelligent manufacturing, and green processes. Chen Wenting, Chairman of Laviana Pharma, Jin Jing, General Manager of the Cangzhou company, and Guo Weitao, Executive Vice President, accompanied the visit and engaged in in-depth discussions on international development.

Under the leadership of Chairman Chen Wenting, the delegation of the Federation of Returned Overseas Chinese visited the corporate culture corridor, the science and technology achievements exhibition area, and the intelligent central control room in succession. Through on-site inspections, the leaders gained a direct understanding of Laviana Pharma’s achievements in R&D innovation, intelligent production, and green, low-carbon, and environmentally friendly practices. During their visit to the intelligent central control room, the Federation leaders highly praised Laviana Pharma’s “Integrated Intelligent Production Management System.” By integrating modules such as equipment control, production execution, and enterprise resource planning, the system enables full-process digital management, resulting in a significant improvement in production efficiency.

During the exchange, Chairman Chen Wenting introduced that Laviana Pharma has technological advantages in the field of pharmaceutical chemical synthesis. Through innovative chemical synthesis routes, it has not only shortened the process steps but also improved R&D efficiency and reduced R&D costs. At the same time, with core technologies such as biocatalysis and continuous-flow microreaction, it has broken through the bottlenecks of high energy consumption and high pollution in traditional processes. Taking the synthesis of a certain antitumor drug as an example, its innovative route reduced the steps from 12 to 6, and the related technology has reached an international leading level. At present, Laviana Pharma has served more than 300 well-known domestic and international pharmaceutical companies, completed thousands of process R&D projects, and helped dozens of drugs successfully enter the market.

Fu Huidong, Chairman of the Provincial Federation of Returned Overseas Chinese, stated that the Federation has always been committed to playing a bridging role, providing enterprises with support in policies, resource matching, and market expansion. In the future, the Federation will further strengthen communication and cooperation with enterprises, help them broaden their international markets, and promote more innovative achievements to the world. At the same time, the Federation will continue to pay close attention to enterprise needs, coordinate with relevant departments, and create a better policy environment for business development.

This research marks the beginning of deep cooperation between the Federation of Returned Overseas Chinese and innovative pharmaceutical enterprises. In the future, both sides will jointly explore a 'government-enterprise-overseas Chinese' linkage model, accelerate the global transformation of China's pharmaceutical R&D achievements, and inject new momentum into the Healthy China strategy.